You are here: Industry Insights > Covaxin

News List

The Lancet publishes Bharat Biotech’s Covaxin phase-III data ExpressPharma
November 15, 2021
Bharat Biotech today announced that the safety and efficacy analysis data from phase-III clinical trials of Covaxin is peer-reviewed and published in The Lancet, the company said in a statement.
Ocugen seeks FDA EUA for Covid-19 vaccine use in children Pharmaceutical-Technology
November 08, 2021
Ocugen has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Covid-19 vaccine candidate, BBV152, for use in children in the age group of two to 18 years.
WHO grants emergency use listing to Bharat Biotech’s Covaxin Pharmaceutical-Technology
November 05, 2021
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) to Indian company Bharat Biotech’s Covid-19 vaccine, Covaxin, for use in individuals aged 18 years and above.
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials ExpressPharma
October 29, 2021
Ocugen, Bharat Biotech’s US partner for COVID-19 vaccine Covaxin, yesterday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) to conduct clinical trials.
Review of Covaxin underway, expect a recommendation within 24 hours: WHO ExpressPharma
October 28, 2021
A technical advisery group of the World Health Organization (WHO) was yesterday reviewing data on Covaxin for the Emergency Use Listing (EUL) of India’s indigenously-made vaccine and if it is satisfied...
CDSCO approves study on mixing of Covaxin and Covishield doses expresspharma
August 13, 2021
"The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the inoculation course," a source said.
Centre approves Bharat Biotech’s Ankleshwar plant for Covaxin production: Mandaviya expresspharma
August 12, 2021
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its Ankleshwar-based facility.
ICMR says Covaxin-Covishield combination shows better results expresspharma
August 10, 2021
The Indian Council of Medical Research (ICMR), in its recent study, mentioned that mixing and matching of COVID-19 vaccines, namely Covaxin and Covishield, showed better results.
Covaxin subjected to over 200 quality control tests, claims Bharat Biotech expresspharma
August 09, 2021
The company released the statement in response to the articles on social media and media outlets regarding the quality of Covaxin.
Mix of Covishield, Covaxin yields better results, finds ICMR Study firstwordpharma
August 09, 2021
A study by ICMR involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second, showed that combining these two COVID-19 vaccines produced better immunogenicity than two doses of the same vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page